A study of oncology staff carried out immediately after the spring peak of the COVID-19 pandemic in the UK indicates…
Artificial intelligence can help to improve prognosis and treatment for glioblastoma
In the first study of its kind in cancer, researchers have applied artificial intelligence to measure the amount of muscle…
NCRI Newsletter | September 2020
UK cancer research could see £167m drop in funding as a result of charity income loss NCRI worked with the…
UK cancer research could see £167m drop in funding as a result of charity income loss
Due to the impact of the Covid-19 pandemic, cancer research charities are predicting their spending on research could drop by…
Making informed decisions in the event of myeloma relapse
Treating relapsed myeloma Around 5,700 people are diagnosed with myeloma in the UK each year. As there is no cure…
Establishing a resource for chronic lymphocytic leukaemia researchers
Biobanks give researchers access to biological material and clinical data on a scale that individual researchers would not be able…
NCRI Newsletter | August 2020
Raising the profile of cancer research Submit your abstract by 13 September for the chance to present your research at the NCRI…
NCRI Newsletter | July 2020
Supporting the development of multidisciplinary research NCRI is pleased to announce that we are accepting proposal submissions for the upcoming…
NCRI Newsletter | June 2020
Collating COVID-19 research projects NCRI is working to collate a list of all the known COVID-19 cancer research projects in…
Interview with Diana Jupp, CEO, Pancreatic Cancer UK
Why did Pancreatic Cancer UK want to become NCRI partners? For decades, too little progress has been made in pancreatic…
Getting to know: Pancreatic Cancer UK
Pancreatic Cancer UK was founded in 2003 by Sue Ballard, whose husband, John, died of pancreatic cancer. She was determined…
NCRI Newsletter | May 2020
Celebrating the contribution of patients and the public 20 May 2020 was International Clinical Trials Day and we celebrated the contribution…